Key result
This review discusses the pathogenesis, clinical manifestations, and management of obesity cardiomyopathy, with an emphasis on the effects of weight reduction.
This review outlines the pathogenesis, clinical manifestations, and management of obesity cardiomyopathy, with a focus on the effects of weight reduction.
Supports weight reduction for obesity cardiomyopathy management; leaves open need for prospective trials before practice change.
Obesity causes a variety of hemodynamic alterations that may lead to changes in cardiac structure and function. Although such abnormalities may occur in patients with mild-to-moderate obesity, they are most pronounced in those with morbid obesity. When these alterations produce congestive heart failure, obesity cardiomyopathy is said to be present. In this review, the authors will first discuss the pathogenesis and clinical manifestations of obesity cardiomyopathy and then describe the management of this clinical syndrome with emphasis on the effects of weight reduction.
No takes yet. Share an insight, caveat, or question.
Alpert et al. (2005) conducted a review in Obesity cardiomyopathy. Weight reduction was evaluated. This review discusses the pathogenesis, clinical manifestations, and management of obesity cardiomyopathy, with an emphasis on the effects of weight reduction.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: